Annual Shareholders Equity
-$586.99 M
-$139.66 M-31.22%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual stockholders equity is -$586.99 million, with the most recent change of -$139.66 million (-31.22%) on December 31, 2023.
- During the last 3 years, IBRX annual shareholders equity has fallen by -$467.18 million (-389.94%).
- IBRX annual shareholders equity is now -389.94% below its all-time high of -$119.81 million, reached on December 31, 2020.
Performance
IBRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$745.15 M
-$46.76 M-6.70%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly stockholders equity is -$745.15 million, with the most recent change of -$46.76 million (-6.70%) on September 30, 2024.
- Over the past year, IBRX quarterly shareholders equity has dropped by -$46.76 million (-6.70%).
- IBRX quarterly shareholders equity is now -521.95% below its all-time high of -$119.81 million, reached on December 31, 2020.
Performance
IBRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IBRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.2% | -6.7% |
| 3 y3 years | -389.9% | -16.1% |
| 5 y5 years | - | -16.1% |
IBRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -142.4% | at low | -207.7% | at low |
| 5 y | 5-year | -389.9% | at low | -522.0% | at low |
| alltime | all time | -389.9% | at low | -522.0% | at low |
ImmunityBio Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$745.15 M(+6.7%) |
| Jun 2024 | - | -$698.39 M(+0.9%) |
| Mar 2024 | - | -$692.01 M(+17.9%) |
| Dec 2023 | -$586.99 M(+31.2%) | -$586.99 M(+42.6%) |
| Sep 2023 | - | -$411.72 M(-35.9%) |
| Jun 2023 | - | -$642.12 M(+21.4%) |
| Mar 2023 | - | -$528.98 M(+18.3%) |
| Dec 2022 | -$447.33 M | -$447.33 M(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$426.70 M(+1.6%) |
| Jun 2022 | - | -$419.81 M(+25.1%) |
| Mar 2022 | - | -$335.64 M(+38.6%) |
| Dec 2021 | -$242.17 M(+102.1%) | -$242.17 M(+28.5%) |
| Sep 2021 | - | -$188.50 M(+19.3%) |
| Jun 2021 | - | -$157.94 M(-15.0%) |
| Mar 2021 | - | -$185.79 M(+55.1%) |
| Dec 2020 | -$119.81 M | -$119.81 M |
FAQ
- What is ImmunityBio annual stockholders equity?
- What is the all time high annual shareholders equity for ImmunityBio?
- What is ImmunityBio annual shareholders equity year-on-year change?
- What is ImmunityBio quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ImmunityBio?
- What is ImmunityBio quarterly shareholders equity year-on-year change?
What is ImmunityBio annual stockholders equity?
The current annual shareholders equity of IBRX is -$586.99 M
What is the all time high annual shareholders equity for ImmunityBio?
ImmunityBio all-time high annual stockholders equity is -$119.81 M
What is ImmunityBio annual shareholders equity year-on-year change?
Over the past year, IBRX annual stockholders equity has changed by -$139.66 M (-31.22%)
What is ImmunityBio quarterly stockholders equity?
The current quarterly shareholders equity of IBRX is -$745.15 M
What is the all time high quarterly shareholders equity for ImmunityBio?
ImmunityBio all-time high quarterly stockholders equity is -$119.81 M
What is ImmunityBio quarterly shareholders equity year-on-year change?
Over the past year, IBRX quarterly stockholders equity has changed by -$46.76 M (-6.70%)